These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 35292399)

  • 1. Paliperidone palmitate as model of heat-sensitive drug for long-acting 3D printing application.
    Manini G; Benali S; Mathew A; Napolitano S; Raquez JM; Goole J
    Int J Pharm; 2022 Apr; 618():121662. PubMed ID: 35292399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-acting implantable dosage forms containing paliperidone palmitate obtained by 3D printing.
    Manini G; Deldime M; Benali S; Raquez JM; Goole J
    Int J Pharm; 2021 Jun; 603():120702. PubMed ID: 33989752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3D printing of pharmaceutical oral solid dosage forms by fused deposition: The enhancement of printability using plasticised HPMCAS.
    Oladeji S; Mohylyuk V; Jones DS; Andrews GP
    Int J Pharm; 2022 Mar; 616():121553. PubMed ID: 35131354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of immediate release (IR) 3D-printed oral dosage forms with focus on industrial relevance.
    Fanous M; Gold S; Hirsch S; Ogorka J; Imanidis G
    Eur J Pharm Sci; 2020 Dec; 155():105558. PubMed ID: 32946957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of release modifiers to modulate drug release from fused deposition modelling (FDM) 3D printed tablets.
    Shi K; Salvage JP; Maniruzzaman M; Nokhodchi A
    Int J Pharm; 2021 Mar; 597():120315. PubMed ID: 33540000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proof of concept of a predictive model of drug release from long-acting implants obtained by fused-deposition modeling.
    Manini G; Benali S; Raquez JM; Goole J
    Int J Pharm; 2022 Apr; 618():121663. PubMed ID: 35292398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tailoring amlodipine release from 3D printed tablets: Influence of infill patterns and wall thickness.
    Obeid S; Madžarević M; Ibrić S
    Int J Pharm; 2021 Dec; 610():121261. PubMed ID: 34742830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simplification of fused deposition modeling 3D-printing paradigm: Feasibility of 1-step direct powder printing for immediate release dosage form production.
    Fanous M; Gold S; Muller S; Hirsch S; Ogorka J; Imanidis G
    Int J Pharm; 2020 Mar; 578():119124. PubMed ID: 32035253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3D printed spherical mini-tablets: Geometry versus composition effects in controlling dissolution from personalised solid dosage forms.
    Ayyoubi S; Cerda JR; Fernández-García R; Knief P; Lalatsa A; Healy AM; Serrano DR
    Int J Pharm; 2021 Mar; 597():120336. PubMed ID: 33545280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fabrication of an osmotic 3D printed solid dosage form for controlled release of active pharmaceutical ingredients.
    Gioumouxouzis CI; Tzimtzimis E; Katsamenis OL; Dourou A; Markopoulou C; Bouropoulos N; Tzetzis D; Fatouros DG
    Eur J Pharm Sci; 2020 Feb; 143():105176. PubMed ID: 31809907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance and paroxetine stability in tablets manufactured by fused deposition modelling-based 3D printing.
    Figueiredo S; Fernandes AI; Carvalho FG; Pinto JF
    J Pharm Pharmacol; 2022 Jan; 74(1):67-76. PubMed ID: 34591102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3D printed extended release tablets for once daily use: An in vitro and in vivo evaluation study for a personalized solid dosage form.
    Gültekin HE; Tort S; Tuğcu-Demiröz F; Acartürk F
    Int J Pharm; 2021 Mar; 596():120222. PubMed ID: 33484916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of multiple structured extended release tablets via hot melt extrusion and dual-nozzle fused deposition modeling 3D printing.
    Zhang P; Li J; Ashour EA; Chung S; Wang H; Vemula SK; Repka MA
    Int J Pharm; 2024 Mar; 653():123905. PubMed ID: 38355075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation of 3D Printed Tablet for Rapid Drug Release by Fused Deposition Modeling: Screening Polymers for Drug Release, Drug-Polymer Miscibility and Printability.
    Solanki NG; Tahsin M; Shah AV; Serajuddin ATM
    J Pharm Sci; 2018 Jan; 107(1):390-401. PubMed ID: 29066279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3D printing of immediate-release tablets containing olanzapine by filaments extrusion.
    Bhatt U; Malakar TK; Murty US; Banerjee S
    Drug Dev Ind Pharm; 2021 Aug; 47(8):1200-1208. PubMed ID: 33493008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Effective Technology for the Development of Immediate Release Solid Dosage Forms Containing Low-Dose Drug: Fused Deposition Modeling 3D Printing.
    Gültekin HE; Tort S; Acartürk F
    Pharm Res; 2019 Jun; 36(9):128. PubMed ID: 31250313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of the degradation and in-situ amorphization of the enantiomeric drug escitalopram oxalate during Fused Deposition Modeling (FDM) 3D printing.
    Hoffmann L; Breitkreutz J; Quodbach J
    Eur J Pharm Sci; 2023 Jun; 185():106423. PubMed ID: 36918059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and In vitro Evaluation of FDM 3D-Printed Ellipsoid-Shaped Gastric Floating Tablets with Low Infill Percentages.
    Chen D; Xu XY; Li R; Zang GA; Zhang Y; Wang MR; Xiong MF; Xu JR; Wang T; Fu H; Hu Q; Wu B; Yan GR; Fan TY
    AAPS PharmSciTech; 2019 Nov; 21(1):6. PubMed ID: 31754916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3D-Printed Isoniazid Tablets for the Treatment and Prevention of Tuberculosis-Personalized Dosing and Drug Release.
    Öblom H; Zhang J; Pimparade M; Speer I; Preis M; Repka M; Sandler N
    AAPS PharmSciTech; 2019 Jan; 20(2):52. PubMed ID: 30617660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low temperature fused deposition modeling (FDM) 3D printing of thermolabile drugs.
    Kollamaram G; Croker DM; Walker GM; Goyanes A; Basit AW; Gaisford S
    Int J Pharm; 2018 Jul; 545(1-2):144-152. PubMed ID: 29705104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.